Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 43063-453

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43063-453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063453 Label (43063453)

Label for Atorvastatin Calcium USP 40 mg film-coated tablets, supplied in a package of 30 tablets. The label shows the product NDC 43063-453-30, manufactured by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. The label includes warnings, reorder number 104416, lot D20B58, and expiration date 04/2022, along with dosage instructions placeholders and FDA contact information for reporting side effects.*

FDA Label Image

Figure-01 (Figure 01)

A line chart comparing the cumulative incidence (%) over time (years) between Atorvastatin and Placebo groups. The chart shows two curves, with Atorvastatin depicted as a solid line and Placebo as a dashed line, over an approximate 3.5-year period. The chart includes a hazard ratio (HR=0.64) with confidence interval and a p-value (p=0.0005).*

FDA Label Image

Figure-02 (Figure 02)

A line graph displaying cumulative hazard percentage over time for placebo and atorvastatin groups during a follow-up period of up to 5 years. The x-axis represents time in years, and the y-axis shows cumulative hazard percentage. Two lines depict data: a dashed line for placebo and a solid line for atorvastatin, indicating lower hazard in the atorvastatin group.*

FDA Label Image

Figure-03 (Figure 03)

A line graph showing the percentage of subjects experiencing an event over time, comparing Atorvastatin 10 mg and Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. Two lines track the progression over five years, with Atorvastatin 10 mg represented by a dashed line and Atorvastatin 80 mg by a solid line, alongside a hazard ratio and p-value noted on the graph.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure diagram of atorvastatin calcium showing its molecular framework including associated calcium ions and a separate molecule likely representing a related component or solvent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.